Clinical Effectiveness of First Trimester Pre-eclampsia Screening Program.
NCT04021680 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2000
Last updated 2023-03-29
Summary
To evaluate the clinical effectiveness of this screening program in preventing pre-eclampsia.
Conditions
- Pre-eclampsia
Interventions
- OTHER
-
pre-eclampsia screening program
This screening program included the use of ultrasound, biomarkers and maternal factors in calculating the risk of developing preeclampsia.
Sponsors & Collaborators
-
Gynecologic Oncology Group
collaborator NETWORK -
Far Eastern Memorial Hospital
lead OTHER
Eligibility
- Min Age
- 20 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-06-10
- Primary Completion
- 2025-06-20
- Completion
- 2025-06-20
Countries
- Taiwan
Study Locations
More Related Trials
-
Evaluation of the Performance of a Rapid Pregnancy Diagnostic Test.
NCT03250884 ·Status: COMPLETED
-
Characteristics of Primary and Plasmatic Hemostasis in Preeclampsia
NCT03149250 ·Status: UNKNOWN
-
The Investigation of the Prediction Model and Prevention Strategy of Serious Pregnancy Complications in Hypertensive Disorders of Pregnancy Based on the Chinese Population
NCT05089175 ·Status: UNKNOWN
-
Predicting Late-onset Preeclampsia at 10-14 Weeks of Pregnancy
NCT04075708 ·Status: COMPLETED
-
Prediction of Preeclampsia (PE) at 11-13 Week
NCT03554681 ·Status: COMPLETED
-
Precision Medicine for Prediction & Prevention of Early Pre-eclampsia
NCT04412681 ·Status: UNKNOWN ·Phase: NA
-
Metformin for Preeclampsia Prevention in Pregnant Women With Type 1 Diabetes Mellitus
NCT03570632 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Prevention of Pre-eclampsia Using Metformin: a Randomized Control Trial
NCT04855513 ·Status: UNKNOWN ·Phase: NA
-
Pilot Project Renal and Cardiovascular Tertiary Prevention in Preeclampsia
NCT07151339 ·Status: RECRUITING
-
Relationship Between Aspirin Metabolism and Markers of Metabolic Dysfunction Among Pregnant Persons at Risk of Pre-eclampsia
NCT06802861 ·Status: RECRUITING
-
Cardiovascular Risk After Preeclampsia
NCT05277233 ·Status: RECRUITING
-
RCT on the Efficacy of Methotrexate for the Prevention of GTD
NCT01984099 ·Status: COMPLETED ·Phase: PHASE3
-
Sublingual Microcirculation Change During Pregnancy and Postpartum Period
NCT03476096 ·Status: UNKNOWN
-
Implementation of First-trimester Screening and preventiOn of pREeClAmpSia Trial (FORECAST)
NCT03941886 ·Status: COMPLETED ·Phase: NA
-
Doppler and Biological Second Trimester Placental Insufficiency Screening
NCT00465634 ·Status: COMPLETED
-
Risk Factors of Ectopic Pregnancy
NCT00194207 ·Status: COMPLETED
-
Screening for Preeclampsia With Various Markers in Low-risk Pregnancy Populations
NCT01649128 ·Status: COMPLETED
-
Rescue Regimen and High Dose Methotrexate in Management of Presistent Gestational Trophoplastic Neoplasia
NCT03280979 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Women's Perspective on First-trimester Preeclampsia Screening
NCT05123560 ·Status: UNKNOWN
-
Pulmonary Embolism in Pregnancy: Biomarkers and Clinical Predictive Models
NCT02709174 ·Status: COMPLETED
-
Prediction of Early Pre-eclampsia From Maternal Factors, Biophysical and Biochemical Markers at First Trimester
NCT02990767 ·Status: UNKNOWN
-
Early Placental Insufficiency Screening
NCT01348711 ·Status: TERMINATED
-
Effects of Recurrent PE on Women and Offspring
NCT05134285 ·Status: UNKNOWN
-
First Trimester Risk Assessment Based on Ultrasound and Cell-free DNA vs Combined Screening
NCT04077060 ·Status: COMPLETED ·Phase: NA
-
Trial of Early Screening Test for Pre-eclampsia and Growth Restriction
NCT03674606 ·Status: COMPLETED ·Phase: PHASE4